A meta-analysis of the vascular-related safety profile and efficacy of alpha-adrenergic blockers for symptoms related to benign prostatic hyperplasia
about
Urinating standing versus sitting: position is of influence in men with prostate enlargement. A systematic review and meta-analysisKorean clinical practice guideline for benign prostatic hyperplasiaα1-Blockers in Men with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Obstruction: Is Silodosin Different?Drug interactions between antiretrovirals and drugs used to treat benign prostatic hyperplasia/lower urinary tract symptoms.A pooled analysis of individual patient data from registrational trials of silodosin in the treatment of non-neurogenic male lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH).[Combined treatment of BPS with tamsulosin and finasteride : Literature review and prescription data].Silodosin for benign prostatic hyperplasia.Changes in urination according to the sound of running water using a mobile phone application.Phosphodiesterase type 9 (PDE9) in the human lower urinary tract: an immunohistochemical study.Benign prostatic hyperplasia and male lower urinary tract symptoms (LUTS)Impact of combination therapy 5-alpha reductase inhibitors (5-ARI) plus alpha-blockers (AB) on erectile dysfunction and decrease of libido in patients with LUTS/BPH: a systematic review with meta-analysis.A randomized, comparative, open-label study of efficacy and tolerability of alfuzosin, tamsulosin and silodosin in benign prostatic hyperplasiaA survey of the FAERS database concerning the adverse event profiles of α1-adrenoreceptor blockers for lower urinary tract symptoms.Combined medical treatment using dutasteride and tamsulosin for lower urinary tract symptoms suggestive of benign prostatic hyperplasia.Silodosin for the treatment of benign prostatic hyperplasia: pharmacology and cardiovascular tolerability.Systematic review and meta-analysis of randomized controlled trials evaluating silodosin in the treatment of non-neurogenic male lower urinary tract symptoms suggestive of benign prostatic enlargement.Investigational therapies targeted to the treatment of benign prostatic hyperplasia.Medical management of lower urinary tract symptoms in men with benign prostatic enlargement.Current pharmacological treatment options for male lower urinary tract symptoms.Cardiovascular and ocular safety of α1-adrenoceptor antagonists in the treatment of male lower urinary tract symptoms.Phytotherapy of benign prostatic hyperplasia. A minireview.Effects of strong CYP2D6 and 3A4 inhibitors, paroxetine and ketoconazole, on the pharmacokinetics and cardiovascular safety of tamsulosinSerenoa repens, selenium and lycopene to manage lower urinary tract symptoms suggestive for benign prostatic hyperplasia.Central Nervous System Medication Burden and Serious Falls in Older Nursing Home Residents.Risk for Hip Fracture due to Alpha Blocker Treatment in Korean Women: National Health Insurance Database Study.Effectiveness and safety of silodosin in the treatment of lower urinary tract symptoms in patients with benign prostatic hyperplasia: A European phase IV clinical study (SiRE study).Severe hypotension during general anesthesia in a patient on chronic high-dose Tamsulosin therapyTreatment of lower urinary tract symptoms in benign prostatic hypertrophy with α-blockers.Tamsulosin-induced severe hypotension during general anesthesia: a case report.Effects of α-blocker 'add on' treatment on blood pressure in symptomatic BPH with or without concomitant hypertension.The therapeutic potential of royal jelly in benign prostatic hyperplasia. Comparison with contemporary literature.Effects of silodosin on sexual function - realistic picture from the everyday clinical practice.Rhodobacter sphaeroides Extract Lycogen™ Attenuates Testosterone-Induced Benign Prostate Hyperplasia in Rats.2-Methoxyestradiol Attenuates Testosterone-Induced Benign Prostate Hyperplasia in Rats through Inhibition of HIF-1/TGF-/Smad2 Axis
P2860
Q21090608-747B0EF0-D8E7-47B1-98A6-F69C6F6C25CEQ26766302-A3C0623B-98F9-4603-BAAB-26B69E870050Q28070342-DDDC1B7A-DADA-4641-AAB1-F03426907D79Q30249162-EF9E202D-7A19-420F-9647-894CE805AE65Q30764782-22AEA90F-8FDC-4C5D-938E-25035BF54F88Q31149371-68100611-3002-4C74-A3FB-C3CC63D8E437Q33158241-E04FAD02-61E3-443C-BCE6-5659E1668C46Q33443661-D3234889-154B-43D9-BF99-E9A7F012BB54Q33953840-87869FD8-9B71-4847-8B06-9401CB031ED2Q34003918-235DAD7E-4CC6-4834-AAB5-EA0D46DF6BF1Q34531114-75B0AFC1-6AA4-4546-88CB-7C6BEEBB0713Q36780186-0D9CE3DE-8899-44D2-88D5-887CE726D898Q36909828-BDAE997A-8A9E-4F3F-9BBE-24CD64A3DBCFQ37790387-8DF81C4C-D791-4DBE-9725-105D234FA7B3Q37813129-B9A37139-3859-470A-9C6D-2387CB70E1EFQ38051005-EC1CA2EC-A295-4E8F-AE9C-83A64AB7FC6BQ38073830-ED6DFB32-B79C-4251-84AD-7AD85D986DA4Q38098896-DE8D52F9-FCB4-45CA-A6F0-580F5199959CQ38103891-D2797165-D547-42F5-87C9-2ADFB793F8EFQ38235157-820C3784-DEF2-438E-B69C-3787EE58C52DQ38244144-190CCCE9-DEB8-4F97-9420-07CBF876673CQ38264945-D84D1868-807C-439B-8843-323E7FAD14DAQ38845916-4F237357-29B4-49BD-9F1D-0CCAADCB6807Q38984103-505246FD-5224-4305-9BB9-89A3BE4DB284Q39042961-BFA4A1A7-DF52-4459-8832-7137EF62CAD4Q39926524-9EB234C0-3965-4CF9-8721-5D42CA26D3C8Q41054703-B52C8BEB-08E9-4B7F-BAE5-A0078AD00089Q41092813-6533FDAA-52FC-4C87-B33C-8A2D97DABB4DQ41127474-1F18730B-D21F-404A-B194-248F81D079C4Q41469996-2D0DDC9B-AF63-4E5D-BC07-84831A51EAD7Q48831662-1A90309F-4CF9-406E-9489-2D769F6FD796Q48935484-9D2ADF10-229B-423A-A417-5A56E02E06A5Q52593551-60BACC30-10BD-49D4-9DF1-76687093EE09Q58805809-B165D318-6A17-4F44-8B8D-46D461C7942C
P2860
A meta-analysis of the vascular-related safety profile and efficacy of alpha-adrenergic blockers for symptoms related to benign prostatic hyperplasia
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A meta-analysis of the vascula ...... o benign prostatic hyperplasia
@en
A meta-analysis of the vascula ...... benign prostatic hyperplasia.
@nl
type
label
A meta-analysis of the vascula ...... o benign prostatic hyperplasia
@en
A meta-analysis of the vascula ...... benign prostatic hyperplasia.
@nl
prefLabel
A meta-analysis of the vascula ...... o benign prostatic hyperplasia
@en
A meta-analysis of the vascula ...... benign prostatic hyperplasia.
@nl
P2093
P2860
P31
P921
P1476
A meta-analysis of the vascula ...... o benign prostatic hyperplasia
@en
P2093
P2860
P304
P356
10.1111/J.1742-1241.2008.01880.X
P5008
P577
2008-10-01T00:00:00Z